Abstract:[Objective]To explore the effect of IFN-α2b on inducement to CD25 and against HBV of the patients with chronic hepatitis B in vivo.[Methods]The total of 110 patients were divided into two groups(65 patients with slight chronic hepatitis B,45 patients with moderate chronic hepatitis B),and treated by IFN-α2b for 36 weeks.Before and after PBMC being stimulated with PHA in vitro,the expression of CD25 and its mRNA of PBMC was detected by method of biotin- streptavidin(BSA)and RT-PCR.The levels of HBV-DNA in PBMC and serum were dynamically detected by PCR during the treatment.[Results]The expression of CD25 and its mRNA gradually increased after treatment of IFN-α2b.However,there was significant difference between two groups and the normal control group(P﹤0.05 or 0.01)in silence or in inducement.After the treatment of IFN-α2b for 36 weeks,the total negative rates of HBV-DNA in PBMC,serum and HBeAg of the patients in two groups were 29(44.62%),26(40.00%),39(60.00%),and 11(24.44%),9(20.00%),17(37.78%)respectively.There was significant difference between two groups(P﹤0.05).[Conclusion]There may be a link between the level of CD25 and the pathogenetic condition of patients with chronic hepatitis B.CD25 of active T cells of the patients with chronic hepatitis B can be induced by IFN-α2b,and it plays key role against HBV-DNA in the host's body.Meanwhile,patients with slight chronic hepatitis B have better therapeutic effect.

THE FUNCTION OF IMMUNO-MODULATING ON CD25 BY IFN-α2b IN CHRONIC HEPATITIS B PATIENTS